PaxMedica and PoloMar to investigate emodin in ASD trial
PoloMar Health will sponsor the study while the BRAIN Foundation will provide the funding.
Company News
Cingulate completes Phase III trial of ADHD therapy in adults
Annovis Bio completes patient enrolment in study of Parkinson’s drug
FDA clears EpimAb’s IND for trial of cancer combo therapy
LianBio concludes subject enrolment in Phase III TP-03 trial in China
Azafaros begins subject enrolment in Phase II RAINBOW trial of AZ-3102
Repare reports data from Phase I solid tumours therapy trial
Ventyx completes enrolment in ulcerative colitis and plaque psoriasis trials
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
